Literature DB >> 5941182

Studies on trachoma. V. Clinical observations in a field trial of bivalent trachoma vaccine at three dosage levels in Saudi Arabia.

R L Nichols, S D Bell, E S Murray, N A Haddad, A A Bobb.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1966        PMID： 5941182

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN： 0002-9637            Impact factor:   2.345


× No keyword cloud information.
  16 in total

1.  Expression of MHC class II antigens by conjunctival epithelial cells in trachoma: implications concerning the pathogenesis of blinding disease.

Authors:  D C Mabey; R L Bailey; D Dunn; D Jones; J H Williams; H C Whittle; M E Ward
Journal:  J Clin Pathol       Date:  1991-04       Impact factor: 3.411

2.  Protection against a chlamydial respiratory challenge by a chimeric vaccine formulated with the Chlamydia muridarum major outer membrane protein variable domains using the Neisseria lactamica porin B as a scaffold.

Authors:  Delia F Tifrea; Sukumar Pal; Jeff Fairman; Paola Massari; Luis M de la Maza
Journal:  NPJ Vaccines       Date:  2020-05-08       Impact factor: 7.344

3.  Transient detection of Chlamydial-specific Th1 memory cells in the peripheral circulation of women with history of Chlamydia trachomatis genital tract infection.

Authors:  Rodolfo D Vicetti Miguel; Seth D Reighard; Jean M Chavez; Lorna K Rabe; Samantha A Maryak; Harold C Wiesenfeld; Thomas L Cherpes
Journal:  Am J Reprod Immunol       Date:  2012-08-31       Impact factor: 3.886

Review 4.  Update on Chlamydia trachomatis Vaccinology.

Authors:  Luis M de la Maza; Guangming Zhong; Robert C Brunham
Journal:  Clin Vaccine Immunol       Date:  2017-04-05

5.  VACCINES. A mucosal vaccine against Chlamydia trachomatis generates two waves of protective memory T cells.

Authors:  Georg Stary; Andrew Olive; Aleksandar F Radovic-Moreno; David Gondek; David Alvarez; Pamela A Basto; Mario Perro; Vladimir D Vrbanac; Andrew M Tager; Jinjun Shi; Jeremy A Yethon; Omid C Farokhzad; Robert Langer; Michael N Starnbach; Ulrich H von Andrian
Journal:  Science       Date:  2015-06-19       Impact factor: 47.728

6.  Vaccination with the recombinant major outer membrane protein elicits antibodies to the constant domains and induces cross-serovar protection against intranasal challenge with Chlamydia trachomatis.

Authors:  Delia F Tifrea; Pooja Ralli-Jain; Sukumar Pal; Luis M de la Maza
Journal:  Infect Immun       Date:  2013-03-11       Impact factor: 3.441

7.  Eradicating blinding trachoma: What is working?

Authors:  Imtiaz A Chaudhry
Journal:  Saudi J Ophthalmol       Date:  2009-12-21

8.  Lymphocyte proliferative responses to chlamydial antigens in human chlamydial eye infections.

Authors:  D C Mabey; M J Holland; N D Viswalingam; B T Goh; S Estreich; A Macfarlane; H M Dockrell; J D Treharne
Journal:  Clin Exp Immunol       Date:  1991-10       Impact factor: 4.330

9.  Computational modeling of TC0583 as a putative component of the Chlamydia muridarum V-type ATP synthase complex and assessment of its protective capabilities as a vaccine antigen.

Authors:  Delia F Tifrea; Michael L Barta; Sukumar Pal; P Scott Hefty; Luis M de la Maza
Journal:  Microbes Infect       Date:  2015-12-17       Impact factor: 2.700

10.  Whole genome identification of C. trachomatis immunodominant antigens after genital tract infections and effect of antibiotic treatment of pigtailed macaques.

Authors:  Dorothy L Patton; Andy Teng; Arlo Randall; Xiaowu Liang; Philip L Felgner; Luis M de la Maza
Journal:  J Proteomics       Date:  2014-05-24       Impact factor: 4.044
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.